Presentation TCT 2017 TCT 36: Delayed Coronary Obstruction After Transcatheter Aortic Valve Replacement Presenter: Reginald I. Low, Michael J. Rinaldi, Richard Jabbour October 31, 2017
Presentation TCT 2017 TCT 91: Antithrombotic Therapy Post Transcatheter Aortic Valve Replacement in Patients With No Indication for Anticoagulation Presenter: Kurt Huber, Jamil Abdalla Saad, Dimitrios Alexopoulos, Antonio L. Bartorelli, Bjorn Redfors, Carlos E. Uribe October 31, 2017
Presentation TCT 2017 TCT 51: Impact of Anticoagulation Therapy on Valve Hemodynamics and Clinical Outcomes After Bioprosthetic Aortic Valve Replacement: A Pooled Analysis of the PARTNER2 Trials Presenter: Peter C. Block, Lars Sondergaard, Tarun Chakravarty, MD October 31, 2017
Presentation TCT 2017 TCT 36: Cerebral Embolic Protection During Transfemoral Aortic Valve Replacement Reduces Death and Stroke Compared to Unprotected Procedure in All Subgroups Presenter: Reginald I. Low, Michael J. Rinaldi, Julia Seeger October 31, 2017
Presentation TCT 2017 TCT 50: Impact of Anticoagulation Therapy on Valve Hemodynamic Deterioration Following Transcatheter Aortic Valve Replacement Presenter: Peter C. Block, Lars Sondergaard, Maria Del Trigo, MD October 31, 2017
Presentation TCT 2017 TCT 34: Prediction of Acute Kidney Injury After TAVR by New Biomarkers Presenter: Reginald I. Low, Michael J. Rinaldi, Mani Arsalan, MD October 31, 2017
Presentation TCT 2017 TCT 49: Long-Term Valve Function 5-9 Years After Transcatheter Aortic Valve Implantation: Data From the UK-TAVI Registry. On Behalf of the National Institute for Cardiovascular Outcomes Research (NICOR) Presenter: Peter C. Block, Lars Sondergaard, Daniel J. Blackman October 31, 2017
Presentation TCT 2017 TCT 33: Effect of Percutaneous Paravalvular Leak Closure on Hemolysis Presenter: Reginald I. Low, Michael J. Rinaldi, Sidakpal Panaich, MD October 31, 2017
Presentation TCT 2017 PARTNER 2A and SAPIEN 3 Cost-effectiveness: Cost-effectiveness of TAVR vs SAVR in Intermediate-Risk Patients With Aortic Stenosis Presenter: Patrick W. Serruys, David J. Cohen October 31, 2017
Presentation TCT 2017 Switzerland Presents: Cases Demonstrating TAVR Limitations Presenter: Hyo-Soo Kim, Quang Ngoc Nguyen, Peter Wenaweser October 31, 2017
Presentation TCT 2017 Switzerland Presents: A Case of Severe Symptomatic Aortic Stenosis and Complex Coronary Artery Disease - ECMO Support? Presenter: Hyo-Soo Kim, Quang Ngoc Nguyen, Stephane Noble October 31, 2017
Presentation TCT 2017 Canada Presents: Mitral, Tricuspid, and Aortic Valve Transcatheter Cases Presenter: Hyo-Soo Kim, Quang Ngoc Nguyen, Anita Asgar October 31, 2017
Presentation TCT 2017 Vietnam Presents: Challenging Cases of Mitral Valvuloplasty Presenter: Hyo-Soo Kim, Quang Ngoc Nguyen October 31, 2017
News Conference News TCT 2017 3-D Printing Opportunities Emerge for Cardiologists, Hospitals, and Device Companies Alike Yael L. Maxwell October 31, 2017
Presentation TCT 2017 Case #3 Conclusion: How We Managed This Patient Presenter: Nick Curzen, Rod H. Stables October 31, 2017
Presentation TCT 2017 Case Comments: How Should We Manage This Patient? Presenter: Nick Curzen, Rod H. Stables, Roman Tarasov October 31, 2017
Presentation TCT 2017 Minimally Invasive Transfemoral TAVR Presenter: Francesco Saia, Gerhard C. Schuler, Francesco Burzotta October 31, 2017
Presentation TCT 2017 Korea Presents: A Case of Valve-in-Valve TAVR Presenter: Hyo-Soo Kim, Quang Ngoc Nguyen, Bon-Kwon Koo October 31, 2017
Presentation TCT 2017 Case #3 Introduction: Patient With Previous CABG Undergoes Successful Transfemoral TAVR via a Tortuous Aorta; and a Few Hours Later, He Becomes Hypotensive, Complains of Chest Pain, and Has T-Wave Inversion in V1-V3 Presenter: Nick Curzen, Rod H. Stables October 31, 2017
Presentation TCT 2017 Case Comments: What Does the Literature Tell Us? Presenter: Nick Curzen, Rod H. Stables, Margaret B. McEntegart October 31, 2017